SCHEMBL15930871

SCHEMBL15930871

COCC(=O)C1=C(CN2CCc3ccccc32)NC(=O)NC1c1ccc(Cl)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.75
NPSR1 Q6W5P4 4/20 0.75
GAA P10253 4/20 0.75
ALDH1A1 P00352 3/20 0.75
HTT P42858 3/20 0.75
KDM4E B2RXH2 1/20 0.61
MITF O75030 1/20 0.61
ALOX15 P16050 1/20 0.61
KLF5 Q13887 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
SMN1; SMN2 Q16637 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
USP2 O75604 1/20 0.56
HSD17B10 Q99714 1/20 0.56
POLB P06746 1/20 0.53
TP53 P04637 6/20 0.49
RECQL P46063 1/20 0.48
CREBBP Q92793 1/20 0.48
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10113781 0.86 MAPT (1.00) MAPTNPSR1GAAALDH1A1HTT
SCHEMBL15930870 0.79 SMN1; SMN2 (0.56) MAPTNPSR1GAAALDH1A1HTT
SCHEMBL10113794 0.72 ALDH1A1 (1.00) MAPTNPSR1GAAALDH1A1HTT
SCHEMBL10113757 0.70 MAPT (1.00) MAPTNPSR1GAAALDH1A1HTT
SCHEMBL14418259 0.70 MAPT (0.75) MAPTNPSR1GAAALDH1A1HTT
SCHEMBL10113752 0.69 MAPT (0.85) MAPTNPSR1GAAALDH1A1HTT
SCHEMBL10113749 0.67 TP53 (0.88) MAPTNPSR1GAAALDH1A1HTT
SCHEMBL28567500 0.66 DRD4 (0.61) MAPTGAAALDH1A1KDM4EALOX15
SCHEMBL10113742 0.65 SMN1; SMN2 (1.00) MAPTNPSR1GAAALDH1A1HTT
SCHEMBL7691419 0.63 GUSB (0.52) MAPTNPSR1GAAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9815838-B2 Methods and compositions for treating pain HYDRA BIOSCIENCES, INC. (US) 2017-11-14 US disclosed
US-9815838-B2 Methods and compositions for treating pain HYDRA BIOSCIENCES, INC. (US) 2017-11-14 US disclosed
US-20140221401-A1 METHODS AND COMPOSITIONS FOR TREATING PAIN HYDRA BIOSCIENCES, INC. (US) 2014-08-07 US disclosed
US-20140221401-A1 METHODS AND COMPOSITIONS FOR TREATING PAIN HYDRA BIOSCIENCES, INC. (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221401-A1 METHODS AND COMPOSITIONS FOR TREATING PAIN ACHE, COL2A1, MMP8 MAPT 1311/4885NPSR1 401/4885GAA 876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.